Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InBody CoXKRX:041830 -3.60%86 Market Cap is ₩786,113 Mil as of Sep. 03, 2026. GuruFocus rates XKRX:041830 with a GF Score™ of 86/100 and a GF Value™ of ₩35,473.99 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 860 Medical Devices & Instruments companies, InBody Co ranks better than 71.16% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). InBody Co's share price for the quarter that ended in Jun. 2026 was ₩57800. InBody Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 13 Mil. Therefore, InBody Co's market cap for the quarter that ended in Jun. 2026 was ₩771,457 Mil.
InBody Co's quarterly market cap
declined
from Dec. 2025 (₩436,918 Mil) to Mar. 2026 (₩368,212 Mil) but then
increased
from Mar. 2026 (₩368,212 Mil) to Jun. 2026 (₩771,457 Mil).
InBody Co's annual market cap
declined
from Dec. 2023 (₩330,234 Mil) to Dec. 2024 (₩294,942 Mil) but then
increased
from Dec. 2024 (₩294,942 Mil) to Dec. 2025 (₩436,918 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. InBody Co's Enterprise Value for Today is ₩651,470 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
InBody Co Market Cap Related Terms
InBody Co Market Cap Historical Data
* Premium members only.
The historical data trend for InBody Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:041830 vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, InBody Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InBody Co Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InBody Co's Market Cap distribution charts can be found below:
* The bar in red indicates where InBody Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
InBody Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InBody Co (XKRX:041830) has a Market Cap of ₩786,113 Mil as of Sep. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on InBody Co and its competitors. According to the industry distribution chart, InBody Co ranks #248 out of 860 companies in the Medical Devices & Instruments industry, placing it in the top 28.8%.
Is InBody Co's Market Cap too high?
InBody Co's current Market Cap is ₩786,113 Mil. Based on the distribution chart, InBody Co ranks #248 out of 860 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, InBody Co has a GF Score™ of 86/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InBody Co's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, InBody Co ranks #248 out of 860 companies for Market Cap. This puts InBody Co in the upper half of its industry. The industry median Market Cap is 120.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.96, based on 860 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on InBody Co and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InBody Co's current Market Cap is ₩786,113 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InBody Co stock overvalued right now?
Based on GuruFocus' analysis, InBody Co (XKRX:041830) is currently considered Significantly Overvalued. The stock's GF Value™ is ₩35,473.99, compared to a current price of ₩58,900.00 — trading 66% above its estimated fair value. The current Market Cap is ₩786,113 Mil. InBody Co's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For InBody Co (XKRX:041830), the current Market Cap is ₩786,113 Mil as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InBody Co (XKRX:041830) Overvalued in 2026?
Based on GuruFocus' analysis, InBody Co stock appears to be overvalued.
The current stock price of ₩58,900.00 is trading 66% above its estimated GF Value™ of ₩35,473.99.
GuruFocus considers InBody Co to be Significantly Overvalued.
Key valuation signals for XKRX:041830:
Market Cap: ₩786,113 Mil
GF Value™: ₩35,473.99 vs. price of ₩58,900.00 (66% above fair value)
No single metric tells the full story. See the XKRX:041830 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.
86GF Score
Get the complete analysis for XKRX:041830
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:041830 has been successfully added to your 
